Novacyt S.A.

Company Profile

Company website
Sector
Medical Equipment and Services (Medical Equipment)
Description

Novacyt is an international diagnostics business delivering a broad portfolio of in vitro and molecular diagnostic tests for a wide range of infectious diseases, enabling faster, more accurate, accessible testing to improve healthcare outcomes. The Company provides customers with a seamless sample-to-result workflow using its integrated and scalable instrumentation/solutions. The Company specialises in the design, manufacture, and supply of real-time PCR kits, reagents and a full range of laboratory and qPCR instrumentation for molecular biology research and clinical use. Novacyt offers one of the world's most varied and comprehensive range of qPCR assays, covering human, veterinary, biodefence, environmental, agriculture and food testing. 

Investor Access

30 May
Event information

The company will announce its audited financial results for the year ended 31 December 2023 on Thursday, 30 May 2024.

Investors can sign up to Investor Meet Company for free and add to meet Novacyt S.A. here:

https://www.investormeetcompany.com/novacyt-sa/register-investor

Venue
Online
Time

Thursday, 30 May 2024 at 11.00am BST

Financial Calendar
 Event Date
Year EndDecember
Half  Year EndJune
Preliminary Results*May
Interim Results*September
AGM*August

* Months based on previous announcements of this kind